These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23583992)

  • 21. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).
    Torén K; Vikgren J; Olin AC; Rosengren A; Bergström G; Brandberg J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3407-3413. PubMed ID: 29238185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of systematic intervention for chronic obstructive pulmonary disease in a regional Japanese city based on case detection rate and medical cost.
    Tawara Y; Senjyu H; Tanaka K; Tanaka T; Asai M; Kozu R; Tabusadani M; Honda S; Sawai T
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1531-42. PubMed ID: 26347397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.
    Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S
    Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The analyses of risk factors for COPD in the Li ethnic group in Hainan, People's Republic of China.
    Ding Y; Xu J; Yao J; Chen Y; He P; Ouyang Y; Niu H; Tian Z; Sun P
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2593-600. PubMed ID: 26664107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COPD and disease-specific health status in a working population.
    Nishimura K; Mitsuma S; Kobayashi A; Yanagida M; Nakayasu K; Hasegawa Y; Jones PW
    Respir Res; 2013 Jun; 14(1):61. PubMed ID: 23725096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
    Lee H; Jhun BW; Cho J; Yoo KH; Lee JH; Kim DK; Lee JD; Jung KS; Lee JY; Park HY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3301-3310. PubMed ID: 29180860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Detection of Chronic Obstructive Pulmonary Disease in Primary Care.
    Kobayashi S; Hanagama M; Yanai M;
    Intern Med; 2017 Dec; 56(23):3153-3158. PubMed ID: 28943559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative and qualitative evaluation of spirometry for COPD screening in general practice.
    Soumagne T; Guillien A; Roux P; Laplante JJ; Botebol M; Laurent L; Roche N; Dalphin JC; Degano B
    Respir Med Res; 2020 Mar; 77():31-36. PubMed ID: 32035336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Airflow Limitation Defined by Pre- and Post-Bronchodilator Spirometry in a Community-Based Health Checkup: The Hisayama Study.
    Fukuyama S; Matsumoto K; Kaneko Y; Kan-o K; Noda N; Tajiri-Asai Y; Nakano T; Ishii Y; Kiyohara Y; Nakanishi Y; Inoue H;
    Tohoku J Exp Med; 2016 Feb; 238(2):179-84. PubMed ID: 26888697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of diabetes mellitus in individuals with airflow obstruction in a Japanese general population: The Yamagata-Takahata Study.
    Machida H; Shibata Y; Inoue S; Igarashi A; Tokairin Y; Yamauchi K; Kimura T; Sato K; Nakano H; Nishiwaki M; Kobayashi M; Yang S; Minegishi Y; Furuyama K; Yamamoto T; Watanabe T; Konta T; Ueno Y; Kato T; Kayama T; Kubota I
    Respir Investig; 2018 Jan; 56(1):34-39. PubMed ID: 29325679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match.
    Topalovic M; Exadaktylos V; Decramer M; Berckmans D; Troosters T; Janssens W
    Respirology; 2015 Aug; 20(6):925-31. PubMed ID: 25880716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test in chronic obstructive pulmonary disease with severe airflow limitation].
    Bermudo G; Pomares X; Montón C; Baré M; Monsó E
    Med Clin (Barc); 2014 Oct; 143(8):349-51. PubMed ID: 24210982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan.
    Onishi K; Yoshimoto D; Hagan GW; Jones PW
    Int J Chron Obstruct Pulmon Dis; 2014; 9():563-8. PubMed ID: 24920894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of incidental emphysema with annual lung function decline and future development of airflow limitation.
    Koo HK; Jin KN; Kim DK; Chung HS; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():161-6. PubMed ID: 26893550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which is the Best Screening Strategy for COPD among Smokers in Primary Care?
    Llordés M; Zurdo E; Jaén Á; Vázquez I; Pastrana L; Miravitlles M
    COPD; 2017 Feb; 14(1):43-51. PubMed ID: 27797591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and examination for COPD. Pulmonary function tests].
    Kubota M
    Nihon Rinsho; 2016 May; 74(5):763-7. PubMed ID: 27254943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Issues in pulmonary function testing for the screening and diagnosis of chronic obstructive pulmonary disease.
    Lam DC; Hui CK; Ip MS
    Curr Opin Pulm Med; 2012 Mar; 18(2):104-11. PubMed ID: 22262139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of cigarette smoking on decline in forced expiratory volume in 1s relative to severity of airflow obstruction in a Japanese general population: The Yamagata-Takahata study.
    Sato K; Shibata Y; Inoue S; Igarashi A; Tokairin Y; Yamauchi K; Kimura T; Nemoto T; Sato M; Nakano H; Machida H; Nishiwaki M; Kobayashi M; Yang S; Minegishi Y; Furuyama K; Yamamoto T; Watanabe T; Konta T; Ueno Y; Kato T; Kayama T; Kubota I
    Respir Investig; 2018 Mar; 56(2):120-127. PubMed ID: 29548649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
    Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.